Skip to content

Lobbying by Arthritis Society Canada: its registrations, its lobbyists, the bills it has named and every meeting it has reported with federal office holders since November 2021.

← Lobbying

Organization

Arthritis Society Canada

Meetings this Parliament
0
With MPs
0
Since Nov 2021
39
Active registrations
1

Most recent reported meeting: Nov 6, 2024.

Registrations in effect

In-house (organization) In effect since Mar 31, 2026 Receives government funding

Filed by Patricia Barbato, President and Chief Executive Officer

Lobbyists

  • Cheryl McClellan · Chief Operating Officer
  • Kelly Gorman · Senior Director Public Policy & Government Affairs
  • Sian Bevan · Chief Science Officer

Institutions they may lobby: Canada Foundation for Innovation, Canadian Institutes of Health Research (CIHR), Crown-Indigenous Relations and Northern Affairs Canada (CIRNAC), Employment and Social Development Canada (ESDC), Finance Canada (FIN), Health Canada (HC), House of Commons, Indigenous Services Canada (ISC), Innovation, Science and Economic Development Canada (ISED), Prime Minister's Office (PMO), Public Health Agency of Canada (PHAC), Senate of Canada, Statistics Canada (StatCan)

What they're lobbying on (5)
  • Discussions with government officials about timely access to care and treatment for people living with arthritis (including pharmacare, addressing wait times, models of care, and pain management).
  • Excise Tax Act, specifically with respect to the application of sales tax on medical cannabis
  • Discussions with government officials with respect to policy and regulation of medical cannabis.
  • Discussions with government about strategies and supports to help improve quality of life for people living with arthritis.
  • Advocate for increased government funding for research, innovation and data related to arthritis and to support patient oriented research. Government support for health charities.

Registration 945692-16891-37. Look it up in the official Registry

Reported meetings

Spreadsheet
  • Reported by Patricia Barbato · In-house (organization)

    • Jill Pilgrim · Director of Policy, Health Care Systems and Legal Affairs, Health Canada (HC)
    Discussions with government officials about timely access to care and treatment for people living with arthritis (including pharmacare, addressing wait times, models of care, and pain management). Read more

    Official report

  • Reported by Patricia Barbato · In-house (organization)

    • Ceanray Harris-Read · Assistant to Senator Yussuff, Senate of Canada
    Advocate for increased government funding for research, innovation and data related to arthritis and to support patient oriented research. Government support for health charities. Read more

    Discussion with government official about national pharmacare and timely access to treatment for people living with arthritis including addressing wait times for joint replacement surgery and pain management.

    Official report

  • Reported by Patricia Barbato · In-house (organization)

    • Kiara Nazon · Parliamentary Affairs Advisor to Senator Moodie, Senate of Canada
    • Branavi Raveendran · Special Assistant to Senator Moodie, Senate of Canada
    Advocate for increased government funding for research, innovation and data related to arthritis and to support patient oriented research. Government support for health charities. Read more

    Discussion with government official about national pharmacare and timely access to treatment for people living with arthritis including addressing wait times for joint replacement surgery and pain management.

    Official report

  • Reported by Patricia Barbato · In-house (organization)

    • Jocelyne Voisin · Assistant Deputy Minister, Health Canada (HC)
    • Elizabeth Toller · Director General,Health Care Strategies, Health Canada (HC)
    • Michael Davies · Director, Health Care System Division, Health Canada (HC)
    Discussion with government official about national pharmacare and timely access to treatment for people living with arthritis including addressing wait times for joint replacement surgery and pain management. Read more

    Advocate for increased government funding for research, innovation and data related to arthritis and to support patient oriented research. Government support for health charities.

    Official report

  • Reported by Patricia Barbato · In-house (organization)

    • Finn Long · Policy Advisor, Health Canada (HC)
    • Laurence Lefebvre · Senior Quebec Advisor, Health Canada (HC)
    Discussion with government official about national pharmacare and timely access to treatment for people living with arthritis including addressing wait times for joint replacement surgery and pain management. Read more

    Advocate for increased government funding for research, innovation and data related to arthritis and to support patient oriented research. Government support for health charities.

    Official report

  • Reported by Patricia Barbato · In-house (organization)

    • Elaine Cote · Member's Assistant to MP Julian, Health Canada (HC)
    Discussion with government official about national pharmacare and timely access to treatment for people living with arthritis including addressing wait times for joint replacement surgery and pain management. Read more

    Advocate for increased government funding for research, innovation and data related to arthritis and to support patient oriented research. Government support for health charities.

    Official report

  • Reported by Patricia Barbato · In-house (organization)

    Advocate for increased government funding for research, innovation and data related to arthritis and to support patient oriented research. Government support for health charities. Read more

    Discussion with government official about national pharmacare and timely access to treatment for people living with arthritis including addressing wait times for joint replacement surgery and pain management.

    Official report

  • Reported by Patricia Barbato · In-house (organization)

    Advocate for increased government funding for research, innovation and data related to arthritis and to support patient oriented research. Government support for health charities. Read more

    Discussion with government official about national pharmacare and timely access to treatment for people living with arthritis including addressing wait times for joint replacement surgery and pain management.

    Official report

  • Reported by Patricia Barbato · In-house (organization)

    • Arif Virani · Minister of Justice and Attorney General, House of Commons
    Advocate for increased government funding for research, innovation and data related to arthritis and to support patient oriented research. Government support for health charities. Read more

    Discussion with government official about national pharmacare and timely access to treatment for people living with arthritis including addressing wait times for joint replacement surgery and pain management.

    Official report

  • Reported by Patricia Barbato · In-house (organization)

    • Larry Maguire · Member of Parliament, House of Commons
    Advocate for increased government funding for research, innovation and data related to arthritis and to support patient oriented research. Government support for health charities. Read more

    Discussion with government official about national pharmacare and timely access to treatment for people living with arthritis including addressing wait times for joint replacement surgery and pain management.

    Official report

  • Reported by Patricia Barbato · In-house (organization)

    • Francesco Sorbara · Member of Parliment, House of Commons
    Advocate for increased government funding for research, innovation and data related to arthritis and to support patient oriented research. Government support for health charities. Read more

    Discussion with government official about national pharmacare and timely access to treatment for people living with arthritis including addressing wait times for joint replacement surgery and pain management.

    Official report

  • Reported by Patricia Barbato · In-house (organization)

    Discussion with government official about national pharmacare and timely access to treatment for people living with arthritis including addressing wait times for joint replacement surgery and pain management. Read more

    Advocate for increased government funding for research, innovation and data related to arthritis and to support patient oriented research. Government support for health charities.

    Official report

  • Reported by Patricia Barbato · In-house (organization)

    • Leah Taylor Roy · Member of Parliament, House of Commons
    Advocate for increased government funding for research, innovation and data related to arthritis and to support patient oriented research. Government support for health charities. Read more

    Discussion with government official about national pharmacare and timely access to treatment for people living with arthritis including addressing wait times for joint replacement surgery and pain management.

    Official report

  • Reported by Patricia Barbato · In-house (organization)

    • Robert Kitchen · Member of Parlilament, House of Commons
    Discussion with government official about national pharmacare and timely access to treatment for people living with arthritis including addressing wait times for joint replacement surgery and pain management. Read more

    Advocate for increased government funding for research, innovation and data related to arthritis and to support patient oriented research. Government support for health charities.

    Official report

  • Reported by Patricia Barbato · In-house (organization)

    • Eshan Naik · Director of Policy, Health Canada (HC)
    • Dylan Bissonnette · Senior Policy Advisor, Health Canada (HC)

    HealthTaxation and Finance

    Official report

  • Reported by Patricia Barbato · In-house (organization)

    • Joanna Lam · Policy and Regional Affairs Advisor, Indigenous Services Canada (ISC)

    Health

    Official report

  • Reported by Patricia Barbato · In-house (organization)

    • Fatima Asghar · Policy Advisor, Health Canada (HC)

    BudgetHealth

    Official report

  • Reported by Patricia Barbato · In-house (organization)

    • Chelsea Madryga · Parliamentary Secretary Assistant, Health Canada (HC)

    Health

    Official report

  • Reported by Patricia Barbato · In-house (organization)

    • Robert Ktichen · Member of Parliament, House of Commons

    HealthResearch and Development

    Official report

  • Reported by Patricia Barbato · In-house (organization)

    • Elizabeth Wong · Policy & Operations Advisor, Employment and Social Development Canada (ESDC)

    Employment and TrainingHealth

    Official report

  • Reported by Patricia Barbato · In-house (organization)

    HealthResearch and Development

    Official report

  • Reported by Patricia Barbato · In-house (organization)

    • Yash Nanda · Policy Advisor, Finance Canada (FIN)

    HealthResearch and DevelopmentTaxation and Finance

    Official report

  • Reported by Patricia Barbato · In-house (organization)

    • Mark Nafekh · Director General, Public Health Agency of Canada (PHAC)
    • Linda Diaz · Deputy Director, Canadian Institutes of Health Research (CIHR)
    • Amahnda Powers · A/Chief of Staff, Public Health Agency of Canada (PHAC)
    • Jean-Francois Leroux · Manager, Chronic Pain Policy Team, Health Canada (HC)

    HealthResearch and Development

    Official report

  • Reported by Patricia Barbato · In-house (organization)

    • Robert Kitchen · Member of Parlilament, House of Commons

    HealthResearch and DevelopmentScience and Technology

    Official report

  • Reported by Patricia Barbato · In-house (organization)

    • Nathanielle Morin · Senior policy advisor, Health Canada (HC)
    • Jared Valdes · Senior Parliamentary Affairs Advisor, Health Canada (HC)
    • Chelsea Madryga · Parliamentary Secretary Assistant, Health Canada (HC)

    HealthResearch and Development

    Official report

From the Office of the Commissioner of Lobbying's open data, published November 5, 2026. Reports cover oral, arranged meetings with designated public office holders since November 22, 2021; lobbyists file them by the 15th of the following month. Names of MPs are matched to the current House of Commons, and bills are linked when the lobbyist's own description makes clear which bill it means. Contains information licensed under the Open Data Licence Agreement — Office of the Commissioner of Lobbying. Licence. PolitiKit is independent and is not endorsed by the Commissioner of Lobbying.